KRISTINA MOULE: Open Payments
NPI 1891969309 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 30 payments from 7 companies in 2025. Trend: 2023 $518 · 2024 $561 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $182 |
| Novartis Pharmaceuticals Corporation | 7 | $159 |
| PFIZER INC. | 9 | $135 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: JARDIANCE, LEQVIO, ELIQUIS, FARXIGA, VYNDAQEL, INSPIRE, Repatha, Wegovy.
Industry payments across NY — which companies pay providers there.
